Shares of Hikma Pharmaceuticals PLC HIK rallied 1.64% to £18.01 Thursday, on what proved to be an all-around poor trading ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...

The Pharmaceutical Quality by Design (QbD) course provides an understanding of the challenges faced by the pharmaceutical and healthcare industries as they strive to develop new products. It will ...

FMI’s latest analysis underscores a remarkable surge in demand for pharmaceutical products within the Kingdom, with market value expected to exceed USD 10,113.1 million by 2024. This impressive growth ...

Our graphic design program places you ahead of the curve. Courses enhance your basic skills in concept, type, layout, and color while providing training in industry-standard software. Students ...

Strategic Design and Management Students Newly Entering Fall 2025: The program will be offered entirely in person; no online option will be offered. Bringing together design thinking, management, and ...

Tamara de Lempicka’s first major U.S. survey invokes her as a trailblazing techno-feminist who borrowed freely from art history. But it also buries her erratic second act. By Walker Mimms ...

With many various solutions on the market, finding the best website design software for your needs is no easy task. To help make your decision easier, Forbes Advisor analyzed the leading options ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...